Want to see HUM full AI Analyst Report?

Humana (HUM) Stock Forecast & Price Target

2,721 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HUM Analyst Ratings

Hold

7 Buy

11 Hold

2 Sell

Based on 20 analysts giving stock ratings to

Humana

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

$334.63

▲(63.12% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $334.63 with a high forecast of $502.00 and a low forecast of $195.00. The average price target represents a 63.12% change from the last price of $205.14.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"175":"$175","257":"$257","339":"$339","421":"$421","503":"$503"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":502,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$502.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":334.6315789473684,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$334.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":195,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$195.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[175,257,339,421,503],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,416.5415384615385,423.6630769230769,430.7846153846154,437.90615384615387,445.0276923076923,452.14923076923077,459.27076923076925,466.39230769230767,473.51384615384615,480.6353846153846,487.75692307692304,494.8784615384615,{"y":502,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,403.667044534413,397.91408906882594,392.16113360323885,386.4081781376518,380.6552226720648,374.90226720647775,369.14931174089065,363.3963562753036,357.6434008097166,351.89044534412955,346.13748987854245,340.3845344129554,{"y":334.6315789473684,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,409.42,392.92615384615385,376.4323076923077,359.9384615384615,343.4446153846154,326.9507692307692,310.4569230769231,293.9630769230769,277.46923076923076,260.9753846153846,244.48153846153843,227.9876923076923,211.49384615384614,{"y":195,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":248.987,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.742,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":299.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":244.109,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.19,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.617,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":254.235,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.815,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.895,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.533,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":233.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.537,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":409.42,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$502.00

Average Price Target$334.63

Lowest Price Target$195.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stephen Baxter

Wells Fargo

$502

Buy

144.71%

Upside

Assigned

07/15/26

Humana upgraded to Overweight from Equal Weight at Wells FargoHumana upgraded to Overweight from Equal Weight at Wells Fargo

David S Macdonald

Truist Financial

$320→$415

Hold

102.30%

Upside

Reiterated

07/14/26

Humana price target raised to $415 from $320 at TruistHumana price target raised to $415 from $320 at Truist

Ryan Langston

TD Cowen

$350

Hold

70.62%

Upside

Assigned

07/14/26

Humana Target Raised to $350 as Medicare Advantage Outlook Improves, but Execution Risks Keep Rating at Hold

Ann Hynes

Mizuho Securities

$390→$468

Buy

128.14%

Upside

Reiterated

07/13/26

Mizuho Securities Keeps Their Buy Rating on Humana (HUM)

Ben Hendrix

RBC Capital

$246→$415

Hold

102.30%

Upside

Reiterated

07/09/26

Humana price target raised to $415 from $246 at RBC CapitalHumana price target raised to $415 from $246 at RBC Capital

Sarah James

Cantor Fitzgerald

$264→$300

Hold

46.24%

Upside

Reiterated

07/07/26

Humana price target raised to $300 from $264 at Cantor FitzgeraldHumana price target raised to $300 from $264 at Cantor Fitzgerald

Kevin Fischbeck

Bank of America Securities

$340→$380

Hold

85.24%

Upside

Reiterated

06/24/26

Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), UnitedHealth (NYSE: UNH) and Humana (NYSE: HUM)

Lance Wilkes

Bernstein

$425

Buy

107.18%

Upside

Reiterated

06/09/26

Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Humana (NYSE: HUM)

Lisa Gill

J.P. Morgan

$214→$316

Hold

54.04%

Upside

Reiterated

06/08/26

Humana price target raised to $316 from $214 at JPMorganHumana price target raised to $316 from $214 at JPMorgan

Erin Wright

Morgan Stanley

$217→$249

Sell

21.38%

Upside

Assigned

06/04/26

Humana price target raised to $249 from $217 at Morgan StanleyHumana price target raised to $249 from $217 at Morgan Stanley

Andrew Mok CFA

Barclays

$180→$344

Hold

67.69%

Upside

Reiterated

05/26/26

Humana price target raised to $344 from $180 at BarclaysHumana price target raised to $344 from $180 at Barclays

A.J. Rice

UBS

$262→$320

Hold

55.99%

Upside

Reiterated

05/22/26

Humana price target raised to $320 from $262 at UBSHumana price target raised to $320 from $262 at UBS

George Hill

Deutsche Bank

$235→$441

Buy

114.98%

Upside

Upgraded

05/20/26

Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank

Jessica Tassan

Piper Sandler

$182→$254

Hold

23.82%

Upside

Reiterated

05/13/26

Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler

John Ransom

Raymond James

$230→$260

Buy

26.74%

Upside

Reiterated

05/01/26

Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stephen Baxter

Wells Fargo

$502

Buy

144.71%

Upside

Assigned

07/15/26

Humana upgraded to Overweight from Equal Weight at Wells FargoHumana upgraded to Overweight from Equal Weight at Wells Fargo

David S Macdonald

Truist Financial

$320→$415

Hold

102.30%

Upside

Reiterated

07/14/26

Humana price target raised to $415 from $320 at TruistHumana price target raised to $415 from $320 at Truist

Ryan Langston

TD Cowen

$350

Hold

70.62%

Upside

Assigned

07/14/26

Humana Target Raised to $350 as Medicare Advantage Outlook Improves, but Execution Risks Keep Rating at Hold

Ann Hynes

Mizuho Securities

$390→$468

Buy

128.14%

Upside

Reiterated

07/13/26

Mizuho Securities Keeps Their Buy Rating on Humana (HUM)

Ben Hendrix

RBC Capital

$246→$415

Hold

102.30%

Upside

Reiterated

07/09/26

Humana price target raised to $415 from $246 at RBC CapitalHumana price target raised to $415 from $246 at RBC Capital

Sarah James

Cantor Fitzgerald

$264→$300

Hold

46.24%

Upside

Reiterated

07/07/26

Humana price target raised to $300 from $264 at Cantor FitzgeraldHumana price target raised to $300 from $264 at Cantor Fitzgerald

Kevin Fischbeck

Bank of America Securities

$340→$380

Hold

85.24%

Upside

Reiterated

06/24/26

Analysts Offer Insights on Healthcare Companies: Cencora (NYSE: COR), UnitedHealth (NYSE: UNH) and Humana (NYSE: HUM)

Lance Wilkes

Bernstein

$425

Buy

107.18%

Upside

Reiterated

06/09/26

Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Jazz Pharmaceuticals (NASDAQ: JAZZ) and Humana (NYSE: HUM)

Lisa Gill

J.P. Morgan

$214→$316

Hold

54.04%

Upside

Reiterated

06/08/26

Humana price target raised to $316 from $214 at JPMorganHumana price target raised to $316 from $214 at JPMorgan

Erin Wright

Morgan Stanley

$217→$249

Sell

21.38%

Upside

Assigned

06/04/26

Humana price target raised to $249 from $217 at Morgan StanleyHumana price target raised to $249 from $217 at Morgan Stanley

Andrew Mok CFA

Barclays

$180→$344

Hold

67.69%

Upside

Reiterated

05/26/26

Humana price target raised to $344 from $180 at BarclaysHumana price target raised to $344 from $180 at Barclays

A.J. Rice

UBS

$262→$320

Hold

55.99%

Upside

Reiterated

05/22/26

Humana price target raised to $320 from $262 at UBSHumana price target raised to $320 from $262 at UBS

George Hill

Deutsche Bank

$235→$441

Buy

114.98%

Upside

Upgraded

05/20/26

Humana upgraded to Buy from Hold at Deutsche BankHumana upgraded to Buy from Hold at Deutsche Bank

Jessica Tassan

Piper Sandler

$182→$254

Hold

23.82%

Upside

Reiterated

05/13/26

Humana price target raised to $254 from $182 at Piper SandlerHumana price target raised to $254 from $182 at Piper Sandler

John Ransom

Raymond James

$230→$260

Buy

26.74%

Upside

Reiterated

05/01/26

Humana price target raised to $260 from $230 at Raymond JamesHumana price target raised to $260 from $230 at Raymond James

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

ENOVEnovis

GKOSGlaukos

IMUXImmunic

AVTXAvalo Therapeutics

TARAProtara Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months

Michael WiederhornOppenheimer

Success Rate

25/39 ratings generated profit

Average Return

+4.16%

Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 64.10% of your transactions generating a profit, with an average return of +4.16% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

24/39 ratings generated profit

Average Return

+10.97%

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +10.97% per trade.

2 Years

Michael WiederhornOppenheimer

Success Rate

31/39 ratings generated profit

Average Return

+22.19%

Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 79.49% of your transactions generating a profit, with an average return of +22.19% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HUM has received 9 Buy Ratings, 14 Hold Ratings, and 2 Sell Ratings. HUM average Analyst price target in the past 3 months is 334.63.

Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is $7.25 with a range of $5.39 to $7.94. The previous quarter’s EPS was $10.31. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is $40.57B with a range of $40.00B to $41.30B. The previous quarter’s sales results were $39.65B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is HUM’s average 12-month price target, according to analysts?

Based on analyst ratings, Humana’s 12-month average price target is 334.63.

What is HUM’s upside potential, based on the analysts’ average price target?

Humana has 63.12% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HUM a Buy, Sell or Hold?

Humana has a consensus rating of Hold which is based on 7 buy ratings, 11 hold ratings and 2 sell ratings.

What is Humana’s price target?

The average price target for Humana is 334.63. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $502.00 ,the lowest forecast is $195.00. The average price target represents 63.12% Increase from the current price of $205.14.

What do analysts say about Humana?

Humana’s analyst rating consensus is a Hold. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of HUM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Humana (HUM) Stock Forecast & Price Target

HUM Analyst Ratings

HUM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Humana

HUM Analyst Recommendation Trends

HUM Financial Forecast

HUM Earnings Forecast

HUM Sales Forecast

HUM Stock Forecast FAQ

Detailed List of Analyst Forecasts